Skip to content
10-Q

Quarterly Report

MOMENTA PHARMACEUTICALS INC

0001235010-19-000009

← back to feed
Filed
Nov 4, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 22, 2019 98.92M sh
Capex Q3 2019 · Sep 30, 2019 $1.74M
Capex Q3 2019 · Sep 30, 2018 $8.59M
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$166.83M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$121.39M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $122.13M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $248.33M
Stockholders Equity Q3 2019 · Sep 30, 2019 $275.92M
Stockholders Equity Q3 2019 · Jun 30, 2019 $312.72M
Stockholders Equity Q3 2019 · Mar 31, 2019 $422.56M
Stockholders Equity Q3 2019 · Dec 31, 2018 $461.01M
Stockholders Equity Q3 2019 · Sep 30, 2018 $248.76M
Stockholders Equity Q3 2019 · Jun 30, 2018 $281.69M
Stockholders Equity Q3 2019 · Mar 31, 2018 $334.42M
Stockholders Equity Q3 2019 · Dec 31, 2017 $374.15M
Current Liabilities Q3 2019 · Sep 30, 2019 $40.58M
Current Liabilities Q3 2019 · Dec 31, 2018 $51.51M
Total Liabilities Q3 2019 · Sep 30, 2019 $121.84M
Total Liabilities Q3 2019 · Dec 31, 2018 $70.56M
Current Assets Q3 2019 · Sep 30, 2019 $286.14M
Current Assets Q3 2019 · Dec 31, 2018 $441.42M
Total Assets Q3 2019 · Sep 30, 2019 $397.77M
Total Assets Q3 2019 · Dec 31, 2018 $531.56M
Sga Expense Q3 2019 · Sep 30, 2019 $20.08M
Sga Expense Q3 2019 · Sep 30, 2019 $90.9M
Sga Expense Q3 2019 · Sep 30, 2018 $20.44M
Sga Expense Q3 2019 · Sep 30, 2018 $63.58M
Rd Expense Q3 2019 · Sep 30, 2019 $46.11M
Rd Expense Q3 2019 · Sep 30, 2019 $106.21M
Rd Expense Q3 2019 · Sep 30, 2018 $30.73M
Rd Expense Q3 2019 · Sep 30, 2018 $95.31M
Operating Income Q3 2019 · Sep 30, 2019 −$46.09M
Operating Income Q3 2019 · Sep 30, 2019 −$210.81M
Operating Income Q3 2019 · Sep 30, 2018 −$51.82M
Operating Income Q3 2019 · Sep 30, 2018 −$171.66M
Revenue Q3 2019 · Sep 30, 2019 $6.39M
Revenue Q3 2019 · Sep 30, 2019 $15.69M
Revenue Q3 2019 · Sep 30, 2018 $14.88M
Revenue Q3 2019 · Sep 30, 2018 $32.77M